RAB27A and ulcerative colitis: In addition to the insights into the pathology of this disease, we found a new pathway in the mechanism of UC: Rab27A, by regulating miR‐124‐3p, can activate the STAT3/RelA signalling pathway, which may provide novel therapeutic approaches with great impact in ulcerative colitis.